53 results
8-K
FGEN
FibroGen Inc
1 Dec 20
Departure of Directors or Certain Officers
8:05am
and Anesthesia at the University of California, San Francisco where he was an internationally recognized expert on clinical research in acute
8-K
EX-99.1
FGEN
FibroGen Inc
24 Mar 20
Master Supply Agreement
5:24pm
on independent Third Party expert that has the capability of investigating the existence of or source of non-conformity and to the extent necessary … , testing the Product to determine whether it is Conforming or Non-Conforming. If such Third Party expert determines that further testing of Product
S-1/A
EX-10.18
5xsa 07t03w2j54zvd
20 Oct 14
IPO registration (amended)
12:00am
S-1
EX-10.12
s316j5c9fsouqh py1og
1 Oct 14
IPO registration
12:00am
DRS/A
EX-10
0d6siaka
24 Sep 14
Draft registration statement (amended)
12:00am
S-1
EX-10.21
syfrh8lgjqtoo5tr
1 Oct 14
IPO registration
12:00am